It is a real estate and construction private limited company based in Newdelhi, Delhi, India, established in 1990.
1990 | Newdelhi, Delhi, India | AmalgamatedSeagull Drugs Private Limited, a amalgamated private limited company, was established on 15 March 1990 in Newdelhi, Delhi, India. Engaging in real estate builders & developers within the real estate and construction sector, it holds CIN: U24299DL1990PTC039516. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹2.25 M.
Formerly known as Opl Lab Private Limited. It upholds a compliant status. Its leadership includes Amir Chand Sehgal (Director), Neelam Oberoi (Director). It holds no open charges and ₹10.30 Cr settled loans. Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at A-5, New Krishna Park Vikas Puri, Newdelhi, Delhi, 110018.
U24299DL1990PTC039516
039516
15 March 1990
₹2.50 M
₹2.25 M
Roc Delhi
Unlisted
Amalgamated
Explore comprehensive insights into Seagull Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Amir Chand Sehgal | Director | 16 Sep 1996 | Current |
| Neelam Oberoi | Director | 21 Jun 1996 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Seagull Drugs Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 65.15% decrease in profit. The company's net worth observed a substantial decline by a decrease of 24.43%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Seagull Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹103,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Mar 2013 | Citibank N.A | ₹10.30 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Seagull Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Seagull Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Seagull Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Seagull Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was completed.
Progress on Seagull Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Delhi. was documented.
Progress on A charge registered on 11 Mar 2013 via Charge ID 10420181 with Citibank N.A was fully satisfied on 10 Aug 2016. was documented.
A charge with Citibank N.A amounted to Rs. 103.00 M with Charge ID 10420181 was registered on 11 Mar 2013. was recorded as a recent event.
Amir Chand Sehgal was appointed as a Director was appointed as a Director on 16 Sep 1996 & has been associated with this company since 29 years 2 months . was recorded as a recent event.
Progress on Neelam Oberoi was appointed as a Director was appointed as a Director on 21 Jun 1996 & has been associated with this company since 29 years 5 months . was documented.
The CIN of Seagull Drugs Private Limited is U24299DL1990PTC039516.
Seagull Drugs Private Limited is headquartered at A-5, New Krishna Park Vikas Puri, Newdelhi, Delhi, 110018.
Seagull Drugs Private Limited was incorporated on 15 March 1990.
The current directors of Seagull Drugs Private Limited are
The primary industry of Seagull Drugs Private Limited is Real Estate And Construction.
Seagull Drugs Private Limited is unlisted.
The authorized capital of Seagull Drugs Private Limited is ₹2.50 M, and the paid-up capital is ₹2.25 M.
The compliance status of Seagull Drugs Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX